HEPASTEM

Welcome to the Brand page for “HEPASTEM”, which is offered here for Cells originating from the liver, for medical, clinical or veterinary use, in particular liver stem cells or progenitor cells; pharmaceutical preparations for the treatment of liver diseases that require cell therapy medicinal products;biomedical services for diagnosing and treating liver disease in relation to the testing of biological samples to determine the presence and activity of liver cells, in particular, liver stem cells and progenitor cells; medical and veterinary services for the isolation, analysis, processing, and administration of cells originating from the liver and in particular, liver stem cells and progenitor cells for diagnosing and treating liver disease;scientific and biotechnological medical research for the pharmaceutical and health care industry relating to development of new medicinal products for cell therapy; scientific and biotechnological medical research for the pharmaceutical and healthcare industry relating to the new product design, validation in the form of quality control, and development of application methods for using cells, in particular, liver stem cells and progenitor cells; development of methods for storage and transport of cells, in particular, liver stem cells and progenitor cells;.

Its status is currently believed to be active. Its class is unavailable. “HEPASTEM” is believed to be currently owned by “Promethera Therapeutics, Société anonyme”.